Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous blood injection for Achilles tendinopathy
ACTRN12610001020077Phase 3Completed
- Sponsor
- Jake Pearson Sports Medicine
- Start
- Mar 2008
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous blood injection in Achilles tendinitis (AT) (2 arms), sponsored by Jake Pearson Sports Medicine. Primary endpoint: Victorian Institute of Sport Assessment for Achilles (VISA-A) score at 12 weeks. Started Mar 2008; status: completed.
02
Drugs
autologous blood injection
03
Conditions
Achilles tendinitis (AT)
Beyond the preview
Go deeper on ACTRN12610001020077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001020077.